You searched for metabolic diseases - Page 3 of 63

multiOmics Health metabolic disorders precision medicine

Opinion 11 Jul 2022

Precision medicine: the next big leap for metabolic disorders

…metabolic syndrome endotype requires operating at the molecular level. Other than a few rare genetic diseases, metabolic syndrome endotypes cannot be understood by looking purely at genetic mutations in the…

July 11, 2022 - 6 minutesmins - By External Contributor

metabolic disorders chaperones gain thx 1

News and Trends 20 Feb 2018

A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

…genetic metabolic diseases, and a group of Swiss investors based in Lugano, Switzerland, including TiVenture – no financial data for the deal was disclosed. Gain Therapeutics is looking to apply…

February 20, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 5 Sep 2024

Six biotech companies that could revolutionize obesity treatments

…numerous investigational drugs to treat cancer, autoimmune diseases, and metabolic diseases like diabetes and obesity. The two notable obesity drugs of the company are HRS9531, a dual agonist of GLP-1/GIP…

September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 4 Jan 2024

Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases?

Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease. These drugs…

January 4, 2024 - 6 minutesmins - By Roohi Mariam Peter

Best in Biotech 19 Dec 2023

Nine biotech companies to watch in 2024

…a variety of diseases, including oncology, autoimmune diseases, blood disorders, and fibrosis. Capstan’s technology centers around targeted lipid nanoparticles (tLNPs) for delivering mRNA payloads to cells. This approach aims to…

December 19, 2023 - 12 minutesmins - By Jules Adam

Best in Biotech 7 Nov 2023

Eight biotech companies tackling infectious diseases head-on

Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are…

November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…around the world working on and specializing in developing therapies and treatments for people with rare diseases. Research and development involving rare diseases has increased over the past few years,…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 6 Feb 2024

16 UK biotech companies you should know about

…million licensing deal focusing on the discovery of bispecific small molecule drugs for metabolic diseases. They then entered into another research and licensing agreement in 2022, to develop up to…

February 6, 2024 - 18 minutesmins - By Willow Shah-Neville

Best in Biotech 23 Apr 2024

Eight biotechnology companies leading the charge in Poland

…drugs, and has also secured funding from EU programs aimed at fostering innovation. Celon Pharma’s pipeline includes treatments for drug-resistant unipolar depression and metabolic diseases. The company recently completed the…

April 23, 2024 - 7 minutesmins - By Jules Adam

Best in Biotech 13 Mar 2025

Nine biotechs thriving in Seattle in 2025

…most effective for cell-based or antibody-based therapies. With the help of this platform, the company aims to identify and treat autoimmune diseases, cancer, infectious diseases, and neurodegenerative diseases. It has…

March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter

In Depth 19 Sep 2024

Mitochondrial disease treatments: is a breakthrough on the horizon?

…is burgeoning different kinds of R&D programs. And while many of these biotechs zero in on degenerative diseases, startups like U.K.-based MitoRx have shown that even metabolic diseases like obesity…

September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter

In Depth 5 Nov 2024

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

…is a first-in-class antisense oligonucleotide targeting microRNA-22 (miR-22), a non-coding RNA implicated in obesity and related metabolic diseases. By inhibiting miR-22, RES-010 seeks to reprogram metabolic pathways, potentially leading to…

November 5, 2024 - 9 minutesmins - By Jules Adam

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Precision medicine: the next big leap for metabolic disorders

A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

Six biotech companies that could revolutionize obesity treatments

Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases?

Nine biotech companies to watch in 2024

Eight biotech companies tackling infectious diseases head-on

10 biotech companies making a difference in rare diseases

16 UK biotech companies you should know about

Eight biotechnology companies leading the charge in Poland

Nine biotechs thriving in Seattle in 2025

Mitochondrial disease treatments: is a breakthrough on the horizon?

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!